Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma.
- Resource Type
- journal article
- Authors
- Wolchok, Jedd D; Chiarion-Sileni, Vanna; Gonzalez, Rene; Grob, Jean-Jacques; Rutkowski, Piotr; Lao, Christopher D; Cowey, C Lance; Schadendorf, Dirk; Wagstaff, John; Dummer, Reinhard; Ferrucci, Pier Francesco; Smylie, Michael; Butler, Marcus O; Hill, Andrew; Márquez-Rodas, Ivan; Haanen, John B A G; Guidoboni, Massimo; Maio, Michele; Schöffski, Patrick; Carlino, Matteo S
- Source
- Journal of Clinical Oncology; 1/10/2022, Vol. 40 Issue 2, p127-137, 11p
- Subject
- Language
- ISSN
- 0732183X